Huons Global Co., Ltd. (KOSDAQ:084110)

Market Cap	537.75B
Revenue (ttm)	813.69B
Net Income (ttm)	16.24B
Shares Out	12.18M
EPS (ttm)	1,332.95
PE Ratio	33.12
Forward PE	n/a
Dividend	260.00 (0.59%)
Ex-Dividend Date	Aug 20, 2025

Volume	46,930
Average Volume	42,064
Open	44,150
Previous Close	44,150
Day's Range	43,150 - 44,250
52-Week Range	26,800 - 54,900
Beta	1.05
RSI	44.86
Earnings Date	Nov 12, 2025

About Huons Global

Huons Global Co., Ltd. manufactures and sells pharmaceutical products for human health in South Korea and internationally. The company offers oral solid form products in the areas of circulatory system, metabolic, anti-pyretic analgesic anti-inflammatory, musculoskeletal system, digestive system, antihistamine, respiratory system, antibiotic, well-being, urogenital system, other chemotherapeutic, and others; and injections in the areas of anesthetic, antipyretic, analgesic, anti-inflammatory, skeletal muscle relaxant, antispasmodic, antihistami...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1965
• Employees: 118
• Stock Exchange: KOSDAQ
• Ticker Symbol: 084110

Financial Performance

In 2024, Huons Global's revenue was 813.46 billion, an increase of 7.26% compared to the previous year's 758.38 billion. Earnings were 25.79 billion, a decrease of -32.81%.